Andrew Von-Eschenbach, Director at Bausch Health Companies, holds 336.07K shares in Celularity (Ticker: CELU), holds 25.36K shares in Bausch + Lomb Corporation (Ticker: BLCO), holds 0.00 shares in Radius Health (Ticker: ~RDUS).
What was Andrew Von-Eschenbach’s latest transaction?
Andrew Von-Eschenbach latest transaction was an Uninformative Buy of ―.
What was Andrew Von-Eschenbach's most profitable transaction?
Andrew Von-Eschenbach’s most profitable transaction was an Informative Buy of BHC stock on March 11, 2020. The return on the trade was 86.30%.
What is Andrew Von-Eschenbach's role in Bausch Health Companies?
Andrew Von-Eschenbach's role in Bausch Health Companies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.